MIRA
INFORM REPORT
|
Report Date : |
13.02.2007 |
IDENTIFICATION
DETAILS
|
Name : |
SWETA
PHARMA PRIVATE LIMITED |
|
|
|
|
Registered Office : |
Dalamal
House, 4th Floor, Nariman Point, Mumbai-400021, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
19.06.1981 |
|
|
|
|
Com. Reg. No.: |
11-24656 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24239MH1981PTC024656 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMS42222F |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACS5370A |
|
|
|
|
Legal Form : |
Private
Limited Liability Company |
|
|
|
|
Line of Business : |
To
carry on the business as manufacturers, producers, makers, refiners,
processors, formulators, importers, exporters, traders and dealers in
pharmaceutical, antibiotic, medicinal, chemical, biological, immunological
contraceptive and therapeutic products, preparations and substances. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
Maximum Credit Limit : |
|
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject
is an old and established company having moderate track. Company’s
profitability is under severe pressure. It has some accumulated losses.
Payments are reported as slow and delayed. The
company can be considered normal for business dealings at usual trade terms
and conditions, with slight caution initially. |
LOCATIONS
|
Registered Office : |
Dalamal
House, 4th Floor, Nariman Point, Mumbai-400021, Maharashtra, India |
|
Tel. No.: |
91-22-22010336 |
|
Fax No.: |
91-22-22076974 |
|
E-Mail : |
|
|
|
|
|
Factory
1 : |
11, Mansoor
Building, 98, Princess Street, Mumbai, Maharashtra, India |
|
Tel.
No.: |
91-22-22020336 |
|
Fax
No.: |
91-22-22076974 |
DIRECTORS
|
Name : |
Mr.
Bimal Shantilal Doshi |
|
Designation : |
Director |
|
Address : |
1201-A,
Chandanbala Apartment, 4, R.R. Thakkar Marg, Mumbai-400006, Maharashtra,
India |
|
Date of Birth/Age : |
24.01.1964 |
|
Date of Appointment : |
02.09.2003 |
|
|
|
|
Name : |
Mr.
Manish Umed Doshi |
|
Designation : |
Director |
|
Address : |
1201-A,
Chandanbala Apartment, 4, R.R. Thakkar Marg, Mumbai-400006, Maharashtra,
India |
|
Date of Birth/Age : |
07.10.1961 |
|
Date of Appointment : |
12.08.1997 |
|
|
|
|
Name : |
Mrs.
Vandana Manish Doshi |
|
Designation : |
Director |
|
Address : |
202,
Amoli, Sanpada, Navi Mumbai-400705, Maharashtra, India |
|
Date of Birth/Age : |
23.08.1962 |
|
Date of Appointment : |
20.03.1985 |
MAJOR SHAREHOLDERS
|
Names
of Shareholders |
No. of Shares |
|
Mrs.
Vandana M. Doshi |
1702 |
|
Umed
B. Doshi |
10 |
|
Ms.
Amoli M. Doshi |
200 |
|
Mr.
Manish U. Doshi |
100 |
|
Mr.
Manish U. Doshi (HUF) |
100 |
|
Mrs.
Indu U. Doshi |
100 |
BUSINESS DETAILS
|
Line of Business : |
To carry
on the business as manufacturers, producers, makers, refiners, processors,
formulators, importers, exporters, traders and dealers in pharmaceutical,
antibiotic, medicinal, chemical, biological, immunological contraceptive and
therapeutic products, preparations and substances. |
|
|
|
|
Products : |
Pyridine,
Chemical – Leather, Intermediate, Bulk Drugs, Pharmaceutical Raw Materials |
GENERAL
INFORMATION
|
Suppliers : |
v
Amoli
Organics Limited v
Amethi
International v
Aurbino
Pharma Private Limited v
Bharat
Mercantile Company v
Chemphar v
H.H.
Agency v
Maharaja
Clearing and Forwarding Agencies v
Nutech
International FZE v
Pradip
Shah & Associates v
Triveni
Art Printers v
Umedica
Laboratories Private Limited |
|
|
|
|
Customers : |
v
Amore
Chemicals v
Anush
Pharma Limited v
Chemical
House v
D.W.D.
Pharmaceuticals v
Deepen
Drungs v
Life
Line Drugs and Intermediates Private Limited v
Manmill
Chemicals Private Limited v
Medicine
Chember v
Medi
Pharma Drug v
Ruskin
Chempharm v
S.G.
Pharmaceuticals v
Shiva
Traders v
Torrent
Pharmaceuticals Limited v
Madhu
Shipping v
Vidhya
Pharmachem Private Limited |
|
|
|
|
Bankers : |
v
Centurion
Bank, Vapi v
Indian
Overseas Bank |
|
|
|
|
Banking Relations : |
-- |
|
|
|
|
Auditors : |
Pradip
Shah & Associates Chartered
Accountants, F.
No.4, 1st Floor, Subeam Chambers, Sir Vitthaldas Thakersey Marg,
New Marine Lines, Mumbai-400020, Maharashtra |
|
Telefax : |
91-22-22091716/
56550627 |
CAPITAL STRUCTURE
Authorised
Capital :
|
No.
of Shares |
Type |
Value |
Amount |
|
5000 |
Equity
Shares |
Rs.100/- each |
Rs.0.500 millions |
Issued,
Subscribed & Paid-up Capital :
|
No.
of Shares |
Type |
Value |
Amount |
|
2220 |
Equity
Shares |
Rs.100/- each |
Rs.0.222 millions |
FINANCIAL DATA
[all figures are in Rupees
Millions]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.222 |
0.222 |
0.222 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
0.000 |
0.687 |
0.726 |
|
|
4] (Accumulated Losses) |
0.309 |
0.000 |
0.000 |
|
|
NETWORTH |
0.531 |
0.909 |
0.948 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
|
|
|
2] Unsecured Loans |
3.887 |
4.137 |
|
|
|
TOTAL BORROWING |
3.887 |
4.137 |
0.112 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
4.418 |
5.046 |
1.060 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
0.085 |
0.022 |
0.002 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.010 |
0.010 |
0.010 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
6.867
|
2.241 |
4.057 |
|
|
Sundry Debtors |
17.949
|
3.958 |
1.474 |
|
|
Cash & Bank Balances |
0.234
|
0.558 |
0.032 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
2.179
|
0.808 |
0.763 |
|
Total Current Assets |
27.229
|
7.565 |
6.326 |
|
|
Less : CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
23.413
|
2.533 |
5.278 |
|
|
Provisions |
0.112
|
0.018 |
|
|
Total Current Liabilities |
23.525
|
2.551 |
5.278 |
|
|
Net Current Assets |
3.704
|
5.014 |
1.048 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3.799 |
5.046 |
1.060 |
|
PROFIT
& LOSS ACCOUNT
|
PARTICULARS |
|
|
31.03.2006 |
|
Sales Turnover [including other income] |
|
|
1.318 |
|
|
|
|
|
|
Profit/(Loss)
Before Tax |
|
|
(0.207) |
|
Provision
for Taxation |
|
|
0.000 |
|
Profit/(Loss)
After Tax |
|
|
(0.207) |
|
|
|
|
|
|
Import
Value |
|
|
3.847 |
|
|
|
|
|
|
Total
Expenditure |
|
|
1.525 |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
PAT / Total Income |
(%) |
NA
|
NA |
(15.70) |
|
|
|
|
|
|
|
Net
Profit Margin (PBT/Sales) |
(%) |
NA
|
NA |
(15.70) |
|
|
|
|
|
|
|
Return
on Total Assets (PBT/Total
Assets} |
(%) |
NA
|
NA |
(3.27) |
|
|
|
|
|
|
|
Return
on Investment (ROI) (PBT/Networth) |
|
NA
|
NA |
(0.22) |
|
|
|
|
|
|
|
Debt
Equity Ratio (Total
Liability/Networth) |
|
51.62
|
7.36 |
5.57 |
|
|
|
|
|
|
|
Current
Ratio (Current
Asset/Current Liability) |
|
1.16
|
2.96 |
1.20 |
LOCAL AGENCY
FURTHER INFORMATION
Company’s
fixed assets include Motor car, Air Conditioner and Computers.
CMT REPORT [Corruption, Money
laundering & Terrorism]
The
Public Notice information has been collected from various sources including but
not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION
ON DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court
Declaration :
No records exist to suggest that subject is or was the subject of any
formal or informal allegations, prosecutions or other official proceeding for
making any prohibited payments or other improper payments to government
officials for engaging in prohibited transactions or with designated parties.
3] Asset
Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record
on Financial Crime :
Charges or conviction registered
against subject: None
5] Records
on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records
on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal
Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation
with Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation
Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA
INFORM as part of its Due Diligence do provide comments on Corporate Governance
to identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a
company’s management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject
is not known to have contravened any existing local laws, regulations or
policies that prohibit, restrict or otherwise affect the terms and conditions
that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US
Dollar |
1 |
Rs.44.17 |
|
UK
Pound |
1 |
Rs.86.10 |
|
Euro |
1 |
Rs.57.26 |
SCORE &
RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
2 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
1 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
2 |
|
--CREDIT LINES |
1~10 |
1 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
25 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit
history (10%) Market
trend (10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|